Summary
Allograft rejection occurs in up to 70% of high-risk keratoplasty patients. For this reason short-term Cyclosporin treatment was administered for three months to prevent graft loss. Of 23 renal healthy patients, 19 enjoyed long-term graft acceptance. We evaluated in these patiens N-acetyl-β-D-glucosaminidase (NAG) excretion as a marker of renal tubular damage. All patients, except one, showed urinary NAG excretion to be within the normal range. From this we conclude that no renal tubular damage occurs after short-term Cyclosporin treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergstrand A, Bohman S, Farnswor A, Gokel JM, Krause PH, Lang W, Mihatsch MJ, Oppedal B, Sells S, Sibley RK (1985) Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop. Clinical Nephrology 24:107–119
Myers BD (1986) Cyclosporine nephrotoxicity. Kidney Int 30:964–974
Calne RY, Pentlow BD, White DJG, Evans DB, McMasre P, Rolles K, Dunn DC, Thiru S, Craddock GN (1978) Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 2:1323–1327
Calne RY, Wood AJ (1985) Cyclosporine in cadaveric renal transplantation: 3-year follow up of a European multicenter trial. Lancet 2:549–557
Gibey R, Dupond JL, Henry J-C (1984) Urinary N-acetyl-beta-D-Glucosaminidase isoenzyme profiles: a tool for evaluating nephrotoxicity of aminoglycosides and cephalosporins: Clin Chim Acta 137:1–11
Hofmann W, Guder WG (1989) A diagnostic Programme for quantitative Analysis of Proteinuria. J Clin Chem Clin Biochem 27:589–600
Kieselbach G, Göttinger W, Juen S (1989) HLA-Typisierung bei Keratoplastik. Spektr Augenhk 5:199–202
Le Hir M, Dubach UC, Guder WJ (1980) Distribution of acid hydrolases in the nephron of normal and diabetic rats. Int J Biochem 12:41–45
Maruhn D, Fuchs I, Mues G, Bock D (1976) Colorimetric assay ofβ-galactosidase and N-acetyl-β-glucosaminidase in human urine. Clin Chim Acta 73:453–461
Miller K, Huber C, Niederwieser D, Göttinger W (1988) Successful engraftment of high-risk corneal allografts with short-term immunosuppression with SANDIMMUN. Transplant 45:651–653
Orfila A, Overas J, Mir M, Cuevas X, Aubia J, Masramon J (1987) Drugs interacting with SANDIMMUN (SIM) after renal transplantation: management of nephrotoxicity. Kidney Int 32:610
Price RG (1979) Urinary N-acetyl-beta-D-Glucosaminidase as indicator of renal disease. Curr Probl Clin Biochem 9:150–163
Shulman H, Striker C, Deeg HJ, Kennedy M, Storb R, Thomas ED (1981) Nephrotoxicity of cyclosporin A after allogenic marrow transplantation: glomerular thrombosis and tubular injury. N Engl J Med 305:1392–1395
Sibley RK, Rynasiewcz J, Ferguson RM, Fryd D, Sutherland DE, Simmons RL, Najarian JS (1983) Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisolone. Surgery 94:225–234
Stark W, Paton D, Maumenec AE (1972) The results of 102 penetrating keratoplasties using 10-0 monofilament nylon suture. Ophthalmic Surg 3:11–25
Sweny P, Hopper J, Gross M, Varghese Z (1981) Nephrotoxicity of cyclosporin A. Lancet 12:663
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kieselbach, F., Kotanko, P. Urinary excretion of N-acetyl-β-d-glucosaminidase in patients after cyclosporin-treated corneal grafting. Klin Wochenschr 68, 869–871 (1990). https://doi.org/10.1007/BF01662784
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01662784